The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 08, 2020
Filed:
May. 31, 2019
Applicant:
Abcentra, Llc, Los Angeles, CA (US);
Inventors:
Jan Nilsson, Genarp, SE;
Ryan Benjamin Abbott, Tallahassee, FL (US);
Bertrand C. Liang, San Diego, CA (US);
Christopher John Farina, Los Angeles, CA (US);
Stacey Ruiz, Beverly Hills, CA (US);
Assignee:
Abcentra, LLC, Los Angeles, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 37/06 (2006.01); A61P 9/10 (2006.01); A61K 39/395 (2006.01); C07K 16/18 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); C07K 14/435 (2006.01); C07K 14/775 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 9/0019 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61P 9/10 (2018.01); A61P 37/06 (2018.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); C07K 2317/21 (2013.01); C07K 2317/565 (2013.01);
Abstract
Described herein are peptides and antibodies for prevention and/or therapeutic treatment of mammals, including humans, against systemic lupus erythematosus, as well as diagnosing the presence or absence of antibodies related to increased or decreased risk of developing SLE and/or to disease grading, staging, and/or prognosis.